Tumor cells of HNSCC and prostate cancer are stimulated by ADO via ADO receptor (ADORA2) in vitro, indicating a pro-tumorigenic effect of exogenous ADO [26, 27]. The gene discussed is ADO; the disease is prostate carcinoma.